Market closed

Impact BioMedical Inc./$IBO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Impact BioMedical Inc.

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Ticker

$IBO

Trading on

AMEX

Industry

Pharmaceuticals

Employees

2

IBO Metrics

BasicAdvanced
$5.8M
-
-$2.30
-
-
$5.8M
$6.17
$0.46
12M
0.25
0.204
122.675
-3.19%
-6.54%
-139.55%
1.32
-0.41
-1.318
3,095.82%
399.25%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IBO

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Impact BioMedical Inc. stock?

Impact BioMedical Inc. (IBO) has a market cap of $5.8M as of April 16, 2025.

What is the P/E ratio for Impact BioMedical Inc. stock?

The price to earnings (P/E) ratio for Impact BioMedical Inc. (IBO) stock is 0 as of April 16, 2025.

Does Impact BioMedical Inc. stock pay dividends?

No, Impact BioMedical Inc. (IBO) stock does not pay dividends to its shareholders as of April 16, 2025.

When is the next Impact BioMedical Inc. dividend payment date?

Impact BioMedical Inc. (IBO) stock does not pay dividends to its shareholders.

What is the beta indicator for Impact BioMedical Inc.?

Impact BioMedical Inc. (IBO) does not currently have a Beta indicator.